Loading the company…
Loading the company…
Families: Pacemaker, ICD & CRT implantation, Coronary intervention (PCI), EP ablation, Spinal cord & DRG stimulation, Peripheral arterial intervention, Incontinence, prolapse & sacral neuromodulation, DBS & VNS, LAA occlusion & loop recorders, Carotid revascularization, Decompression & minimally invasive spine, Aortic endografts (EVAR/TEVAR), Structural heart (TAVR, TEER) and 17 more.
All companies · Product and company coverage
Vertiflex's surgeons now deal with Boston Scientific. Integration brings new reps, contracts and bundles: for a competitor, a window while it settles; for Boston Scientific, surgeons to keep.
Silk Road Medical's surgeons now deal with Boston Scientific. Integration brings new reps, contracts and bundles: for a competitor, a window while it settles; for Boston Scientific, surgeons to keep.
Axonics's surgeons now deal with Boston Scientific. Integration brings new reps, contracts and bundles: for a competitor, a window while it settles; for Boston Scientific, surgeons to keep.
Payments and FDA records read by the company that owns the business today, so a deal never looks like surgeons switching; a surgeon’s payment history still shows the name each payment was made under.
In the last ten years FDA made 2,193 decisions for Boston Scientific (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 29 procedure families, the most in 2017 (364). The latest was on 2026-10-15.
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-10-15 | PMA | P150031-S100 | Vercise DBS Systems · Labeling Change - Indications/instructions/shelf life/tradename |
| 2026-10-03 | PMA | N970003-S311 | ALTRUA 2 (Model S722); ESSENTIO (Model L121); PROPONENT (Model L221); ACCOLADE (Model L321); ALTRUA 2 (Models S701, · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-10-03 | PMA | P150012-S191 | ESSENTIO MRI (Model L131); PROPONENT MRI (Model L231); ACCOLADE MRI (Model L331); ESSENTIO MRI (Models L110, L111); PRO · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-10-03 | PMA | P030005-S257 | VALITUDE (Model U125); VALITUDE X4 (Model U128); VISIONIST (Models U225, U226); VISIONIST X4 (Model U228) · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-10-02 | PMA | P110042-S216 | EMBLEM Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) high voltage (HV) Capacitor · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Boston Scientific.
In 2025, Boston Scientific reported engagement with 77,014 surgeons and other clinicians in the states MedaRep covers, worth $52M in consulting, speaking, meals and travel for its device products, the most in California ($6.2M to 6,657). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($6.2M, 6,657 engaged), Texas ($4.5M, 6,542 engaged), New York ($4.4M, 4,405 engaged), Florida ($4.1M, 7,911 engaged), Illinois ($2.7M, 2,646 engaged).